Kedrion Biopharma
Blood & Organ Banks · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.kedrab.comRevenue
<$5 MillionIndustry
ZI Rank: 2
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
2
3
3
2
2
About Kedrion Biopharma
Kedrion Biopharma Inc. specializes in human rabies immune globulin (HRIG) with its primary product being KEDRAB, intended for post-exposure prophylaxis (PEP) against rabies in individuals of all ages. The company targets healthcare professionals involved in the treatment of potential rabies exposures, providing comprehensive resources and assurance programs to support their efforts. KEDRAB is designed to ensure effective administration for any exposure and wound type, emphasizing the importance of adequate dosing. The company also offers essential safety information and patient resources to enhance preventive care against rabies.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Kedrion Biopharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Kedrion Biopharma, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Kedrion Biopharma
Check if Kedrion Biopharma has recently received funding, and reach out quickly before it becomes old news!
Click to see if Kedrion Biopharma had a recent Job posting/layoffs
Check out if Kedrion Biopharma is spiking on competitors!
Earning: See what the market has to say on Kedrion Biopharma recently announced quarterly report
Funding: Get notified immidiatlly once Kedrion Biopharma has new funding data
Product Launch: Get notified when Kedrion Biopharma launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Kedrion Biopharma
Find 2 more new buyers
Compare Similar Companies to Kedrion Biopharma
Compare insights from companies similar to Kedrion Biopharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Kedrion Biopharma
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Kedrion Biopharma is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Kedrion Biopharma is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Kedrion Biopharma.
Kedrion Biopharma Tech Stack
A closer look at the technologies used by Kedrion Biopharma
See more technologies
Kedrion Biopharma News & Media
New KEDRAB® Dose Calculator Launches to Help Hospitals in Treating Rabies Exposures
FORT LEE, N.J.--(BUSINESS WIRE)--#kedplasmausa--Launch of KEDRAB Dosage Calculator
Read more news
Top Blood & Organ Banks Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Kedrion Biopharma
Sign Up For FreeTo access detailed company insights
Kedrion Biopharma Inc. specializes in human rabies immune globulin (HRIG) with its primary product being KEDRAB, intended for post-exposure prophylaxis (PEP) against rabies in individuals of all ages. The company targets healthcare professionals involved in the treatment of potential rabies exposures, providing comprehensive resources and assurance... Read More
